Cell volume regulation in epithelial physiology and cancer

Research output: Contribution to journalReviewResearchpeer-review

Standard

Cell volume regulation in epithelial physiology and cancer. / Pedersen, Stine Helene Falsig; Hoffmann, Else Kay; Novak, Ivana.

In: Frontiers in Physiology, Vol. 4, 233, 2013.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Pedersen, SHF, Hoffmann, EK & Novak, I 2013, 'Cell volume regulation in epithelial physiology and cancer' Frontiers in Physiology, vol. 4, 233. https://doi.org/10.3389/fphys.2013.00233

APA

Pedersen, S. H. F., Hoffmann, E. K., & Novak, I. (2013). Cell volume regulation in epithelial physiology and cancer. Frontiers in Physiology, 4, [233]. https://doi.org/10.3389/fphys.2013.00233

Vancouver

Pedersen SHF, Hoffmann EK, Novak I. Cell volume regulation in epithelial physiology and cancer. Frontiers in Physiology. 2013;4. 233. https://doi.org/10.3389/fphys.2013.00233

Author

Pedersen, Stine Helene Falsig ; Hoffmann, Else Kay ; Novak, Ivana. / Cell volume regulation in epithelial physiology and cancer. In: Frontiers in Physiology. 2013 ; Vol. 4.

Bibtex

@article{8460c7217547424aa33100fe2cc1fc81,
title = "Cell volume regulation in epithelial physiology and cancer",
abstract = "The physiological function of epithelia is transport of ions, nutrients, and fluid either in secretory or absorptive direction. All of these processes are closely related to cell volume changes, which are thus an integrated part of epithelial function. Transepithelial transport and cell volume regulation both rely on the spatially and temporally coordinated function of ion channels and transporters. In healthy epithelia, specific ion channels/transporters localize to the luminal and basolateral membranes, contributing to functional epithelial polarity. In pathophysiological processes such as cancer, transepithelial and cell volume regulatory ion transport are dys-regulated. Furthermore, epithelial architecture and coordinated ion transport function are lost, cell survival/death balance is altered, and new interactions with the stroma arise, all contributing to drug resistance. Since altered expression of ion transporters and channels is now recognized as one of the hallmarks of cancer, it is timely to consider this especially for epithelia. Epithelial cells are highly proliferative and epithelial cancers, carcinomas, account for about 90{\%} of all cancers. In this review we will focus on ion transporters and channels with key physiological functions in epithelia and known roles in the development of cancer in these tissues. Their roles in cell survival, cell cycle progression, and development of drug resistance in epithelial cancers will be discussed.",
author = "Pedersen, {Stine Helene Falsig} and Hoffmann, {Else Kay} and Ivana Novak",
year = "2013",
doi = "10.3389/fphys.2013.00233",
language = "English",
volume = "4",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Cell volume regulation in epithelial physiology and cancer

AU - Pedersen, Stine Helene Falsig

AU - Hoffmann, Else Kay

AU - Novak, Ivana

PY - 2013

Y1 - 2013

N2 - The physiological function of epithelia is transport of ions, nutrients, and fluid either in secretory or absorptive direction. All of these processes are closely related to cell volume changes, which are thus an integrated part of epithelial function. Transepithelial transport and cell volume regulation both rely on the spatially and temporally coordinated function of ion channels and transporters. In healthy epithelia, specific ion channels/transporters localize to the luminal and basolateral membranes, contributing to functional epithelial polarity. In pathophysiological processes such as cancer, transepithelial and cell volume regulatory ion transport are dys-regulated. Furthermore, epithelial architecture and coordinated ion transport function are lost, cell survival/death balance is altered, and new interactions with the stroma arise, all contributing to drug resistance. Since altered expression of ion transporters and channels is now recognized as one of the hallmarks of cancer, it is timely to consider this especially for epithelia. Epithelial cells are highly proliferative and epithelial cancers, carcinomas, account for about 90% of all cancers. In this review we will focus on ion transporters and channels with key physiological functions in epithelia and known roles in the development of cancer in these tissues. Their roles in cell survival, cell cycle progression, and development of drug resistance in epithelial cancers will be discussed.

AB - The physiological function of epithelia is transport of ions, nutrients, and fluid either in secretory or absorptive direction. All of these processes are closely related to cell volume changes, which are thus an integrated part of epithelial function. Transepithelial transport and cell volume regulation both rely on the spatially and temporally coordinated function of ion channels and transporters. In healthy epithelia, specific ion channels/transporters localize to the luminal and basolateral membranes, contributing to functional epithelial polarity. In pathophysiological processes such as cancer, transepithelial and cell volume regulatory ion transport are dys-regulated. Furthermore, epithelial architecture and coordinated ion transport function are lost, cell survival/death balance is altered, and new interactions with the stroma arise, all contributing to drug resistance. Since altered expression of ion transporters and channels is now recognized as one of the hallmarks of cancer, it is timely to consider this especially for epithelia. Epithelial cells are highly proliferative and epithelial cancers, carcinomas, account for about 90% of all cancers. In this review we will focus on ion transporters and channels with key physiological functions in epithelia and known roles in the development of cancer in these tissues. Their roles in cell survival, cell cycle progression, and development of drug resistance in epithelial cancers will be discussed.

U2 - 10.3389/fphys.2013.00233

DO - 10.3389/fphys.2013.00233

M3 - Review

VL - 4

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

M1 - 233

ER -

ID: 94834520